SeqOne S.A.S. news
SeqOne Genomics, provider of nextgeneration genomic analysis solutions for personalized medicine, announces the appointment of Hervé Pouzoullic as Chief Commercial Officer (CCO). He will lead the commercial development of the company to accelerate its growth and strengthen its international presence.
Hervé has more than 25 years of experience in sales, business development and general management. He worked at KPMG, Sanofi and, ThermoFisher Scientific in
SeqOne today announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies (CNR-MAT), aimed at improving the diagnosis and management of patients suspected of suffering from thrombotic microangiopathies and atypical Hemolytic syndrome (aHUS). The program involved using Oxford Nanopore’s revolutionary technology to sequence patie
SeqOne Genomics, today announced that Michael Blum, Ph.D. is joining the company to lead its research and development department. He is tasked with driving SeqOne’s R&D strategy notably in the area of rare diseases and oncology through the use of machine learning and data science.
Michael started his career as a biostatistician and bioinformatician at the CNRS where he developed software solutions that enabled complex genomic data analysis for biologists and clinicians. He t
SeqOne Genomics, provider of next-generation genomic analysis solutions for personalized medicine is proud to announce a new strategic partnership with ILC Instrumentos de Laboratório Científicos to facilitate access to its genomic analysis solutions in Portugal. Through this partnership, ILC Instrumentos de Laboratório Científicos has been appointed as a value added distributor in Portugal.
Nicolas Philippe, CEO co-founder of SeqOne Gen
The round, led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors, Elaia and IRDI Capital Investissement, will enable SeqOne Genomics to accelerate its international sales and the development of new collaborative genomic analysis tools to facilitate communications between different disciplines in the medical team, in order to improve patient outcomes in cancer and hereditary disease.
The company will intensify investments in the development of it
SeqOne Genomics, a leader in the field of next generation genomics analysis, announces today a distribution partnership with Global Diagnostic Solutions Ltd (GDS) to commercialize SeqOne’s revolutionary genomics analysis software platform in Middle Eastern markets.
Under the terms of this agreement, Global Diagnostic Solutions Ltd. will be responsible for the Business Development, Technical & Logistics Support of SeqOne’s genomic analysis platform in the Middle-East No
Eighty percent of rare diseases are genetic in origin and result from a small number of genetic mutations. Identifying these variations is essential in diagnosing the diseases and can dramatically improve patient care.
Making Whole Exome sequencing more affordable to improve diagnostic efficiency
Since 2017, Eurofins Biomnis has offered “Whole Exome” sequencing which, starting from a simple blood test, provides information on all the genes relevant
SeqOne a French start-up in the genomic medicine market is proud to announce that it has been awarded an i-Lab grant by the Ministry of Education and Technology. i-Lab is a national competition open to all French start-ups designed to identify the most promising technical innovations by France’s most forward-thinking start-ups. The award is associated with a grant aimed at helping each start up to bring the innovation it is developing to the market.
SeqOne is a pioneering